Stockholders' Equity - At-the-Market Offering (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Jul. 30, 2024 |
|
| Subsidiary, Sale of Stock [Line Items] | |||||||||
| Number of shares authorized to be sold under equity distribution agreement (in shares) | 15,000,000 | ||||||||
| Issuance of stock, net of offering costs | $ 61 | $ 50 | $ 54 | $ 48 | $ 149 | $ 177,729 | |||
| At the Market Offering | |||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||
| Number of shares of stock issued during period (in shares) | 0 | 0 | 117,427 | ||||||
| Issuance of stock, net of offering costs | $ 2,100 | ||||||||
| X | ||||||||||
- Definition The number of shares authorized to be sold under an at-the-market Equity Distribution Agreement. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|